Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data
R Maroun, L Mitrofan, L Benjamin, G Nachbaur… - BMC cancer, 2018 - Springer
Background Patient characteristics and survival outcomes in randomized trials may be
different from those in real-life clinical practice. The objective of this study was to describe …
different from those in real-life clinical practice. The objective of this study was to describe …
Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000–2008)
T Wahlgren, U Harmenberg, P Sandström… - British journal of …, 2013 - nature.com
Background: This retrospective register study assessed overall survival (OS) and influential
factors on OS in Swedish renal cell carcinoma (RCC) patients. Methods: Using three merged …
factors on OS in Swedish renal cell carcinoma (RCC) patients. Methods: Using three merged …
[HTML][HTML] Renal cell carcinoma: how to hit the targets?
O Banyra, M Tarchynets, A Shulyak - Central European journal of …, 2013 - ncbi.nlm.nih.gov
Conclusions The results of the currently used targeted drugs demonstrate perspectives of
metastatic RCC conservative treatment, that are able to prolong cancer–specific survival in …
metastatic RCC conservative treatment, that are able to prolong cancer–specific survival in …
[HTML][HTML] Real-world treatment patterns and clinical outcomes for metastatic renal cell carcinoma in the current treatment era
NJ Shah, SD Sura, R Shinde, J Shi, PK Singhal… - European Urology Open …, 2023 - Elsevier
Background Immuno-oncology (IO) agents and tyrosine kinase inhibitors (TKIs) have
revolutionized the treatment paradigm for metastatic renal cell carcinoma (mRCC). Data on …
revolutionized the treatment paradigm for metastatic renal cell carcinoma (mRCC). Data on …
Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949
PN Lara Jr, CM Tangen, SJ Conlon, RC Flanigan… - The Journal of …, 2009 - Elsevier
PURPOSE: S8949 demonstrated improved overall survival for debulking nephrectomy in
interferon treated patients with advanced renal cell carcinoma. We present an updated …
interferon treated patients with advanced renal cell carcinoma. We present an updated …
Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?
O Rouvière, R Bouvier, S Négrier, L Badet… - Nature clinical practice …, 2006 - nature.com
Defining rational follow-up guidelines in patients treated for cancer is important, from both a
medical and an economical perspective. Renal-cell carcinoma is reputed to be …
medical and an economical perspective. Renal-cell carcinoma is reputed to be …
Current treatment considerations in metastatic renal cell carcinoma
H Haddad, BI Rini - Current treatment options in oncology, 2012 - Springer
Opinion statement In general, debulking neprhectomy is still considered for metastatic RCC
patients with primary tumor in place, assuming good performance status. Initial systemic …
patients with primary tumor in place, assuming good performance status. Initial systemic …
Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: update of the RENCOMP study with subgroup analysis of the …
M Lindskog, T Wahlgren, R Sandin, J Kowalski… - … Oncology: Seminars and …, 2017 - Elsevier
Background This retrospective study investigated overall survival (OS) and factors
influencing OS in Swedish patients with metastatic renal cell carcinoma (mRCC) during the …
influencing OS in Swedish patients with metastatic renal cell carcinoma (mRCC) during the …
Current clinical practice guidelines for the treatment of renal cell carcinoma: a systematic review and critical evaluation
The landscape of local and systemic therapy of renal cell carcinoma (RCC) is rapidly
changing. The increase in the incidental finding of small renal tumors has increased the …
changing. The increase in the incidental finding of small renal tumors has increased the …
[HTML][HTML] Treatment, outcome and prognostic factors in renal cell carcinoma-a single center study (2000-2010)
C Achermann, F Stenner, SI Rothschild - Journal of Cancer, 2016 - ncbi.nlm.nih.gov
In Switzerland efficient availability of novel drugs for renal cell cancer (RCC) has been
granted early. Since the advent of the targeted agents for RCC the usage of these drugs has …
granted early. Since the advent of the targeted agents for RCC the usage of these drugs has …